Do you want to read an article? Please log in or register.
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease
Inflamm Bowel Dis.
Shah NB, Haydek J, Slaughter J, Ashton JR, Zuckerman AD, Wong R, Raffa F, Garrett A, Duley C, Annis K, Wagnon J, Gaines L, Dalal R, Scoville E, Beaulieu DB, Schwartz D, Horst SN
doi: 10.1093/ibd/izz253.
Inflammatory Bowel Disease
Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Inflamm Bowel Dis.
Law CCY, Koh D, Bao Y, Jairath V, Narula N
doi: 10.1093/ibd/izaa020.
Inflammatory Bowel Disease
Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis
Clin Gastroenterol Hepatol.
Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ
doi: 10.1016/j.cgh.2019.02.044.
Inflammatory Bowel Disease
Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy
Inflamm Bowel Dis.
Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM
doi: 10.1093/ibd/izz001.
Inflammatory Bowel Disease
Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases
Clin Gastroenterol Hepatol.
Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S, New York Crohn’s and Colitis Organization (NYCCO).
doi: 10.1016/j.cgh.
RECOMMENDED
Inflammatory Bowel Disease
Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol.
Beaugerie L, Rahier JF, Kirchgesner J
doi: 10.1016/j.cgh.2020.02.009.
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
Inflammatory Bowel Disease
Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases
Inflamm Bowel Dis.
Attauabi M, Zhao M, Bendtsen F, Burisch J
doi: 10.1093/ibd/izaa167.
Inflammatory Bowel Disease
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
Lancet Gastroenterol Hepatol.
Chapman TP, Gomes CF, Louis E, Colombel JF, Satsangi J
doi: 10.1016/S2468-1253(19)30186-4.